Ovarian cancer cells could secrete ThrRS in response to cell stress, and ThrRS levels in patient cancer specimens were correlated with advancing disease stage and vascular endothelial growth factor (VEGF)108. This evidence concerns the gene VEGFA and ovarian cancer.